You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 健友股份(603707.SH)大漲逾8% 子公司獲得美國FDA暫時批准文號
格隆匯 03-25 14:23
格隆匯3月25日丨健友股份(603707.SH)今日股價高開上漲,現大漲8.68%,報50.07元,暫成交2.23億元,最新總市值359.74億元。健友股份24日晚公告,公司子公司香港健友近日收到美國FDA通知,香港健友向美國FDA申報的注射用硼替佐米ANDA申請已獲得暫時批准,標誌着該產品滿足仿製藥的所有審評要求。中泰證券點評稱,硼替佐米ANDA暫時獲批,腫瘤領域持續佈局,注射劑產品加速獲批。預計公司有望較快申報國內並上市,預計該產品將為公司帶來較為客觀的收入利潤。維持“買入”評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account